Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11Mar 02, 2025
Ischemia
Battling Ischemia with Therapeutic Angiogenesis
Zhittya Genesis Medicine
PAO-03-22-R250-11Mar 15, 2022
Accelerated Drug Development for Acute Cardiovascular and Pulmonary Care
Craig Fraser
PA822Aug 25, 2021
Partnership
BioVectra and PhaseBio Discuss Creating an Optimal Partnership
Oliver Technow; David Alvaro, Ph.D.; Jonathan Mow
BIOVECTRA
PTV-04-21-CL-001Apr 15, 2021
Clinical Results
AstraZeneca's Drug Significantly Reduces the Rate of the Composite of Stroke and Death in Patients
AstraZeneca
PR-M07-20-NI-027Jul 16, 2020
Diabetes
Sanofi to Exit Diabetes and Cardiovascular Research
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-19-NI-005Dec 13, 2019
Cell Therapy
CD34+ Cell Therapy in Clinical Trials
Douglas Losordo
Lisata Therapeutics
PAP-Q4-19-CL-012Dec 06, 2019
M&A
Novartis to Acquire The Medicines Company for $9.7 Billion
Novartis
PR-M11-19-NI-031Nov 25, 2019
Drug Pricing
Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Amgen
PR-M10-19-NI-037Oct 25, 2019
Collaboration Agreement
Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence
Huma
PR-M08-19-NI-012Aug 05, 2019
FDA Approval
FDA Approves New Device for Treating Moderate to Severe Chronic Heart Failure in Patients
U.S. Food & Drug Administration
PR-M03-19-NI-068Mar 25, 2019
Drug Development
Novartis Licenses First-in-Class Heart Disease Drug
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-008Mar 05, 2019
Market Prediction
Global Interventional Cardiology Market to Reach $24.96 Billion by 2027
BIS Research
PR-M10-18-NI-098Oct 29, 2018
Cardiovascular
World Heart Day: Nearly One in Five Deaths From Cardiovascular Disease are Caused by Air Pollution, a Total of 3 Million Deaths Globally Every Year
My Heart, Your Heart
PR-M10-18-NI-013Oct 03, 2018
Clinical Results
Fish-Oil Drug Shows Dramatic Results in Cardiovascular Study
Emilie Branch
Pharma's Almanac
PAO-M09-18-NI-025Sep 25, 2018
FDA Approval
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Medicure
PR-M09-18-NI-020Sep 10, 2018
Cardiovascular
Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases
Janssen Pharmaceutical Companies
PR-M04-18-NI-72Apr 20, 2018
Results
Positive Results for Pfizer Drug Tafamidis
Emilie Branch
Pharma's Almanac
PAO-M04-18-NI-001Apr 04, 2018
Innovation
Harvard Researchers Use Chip Technology to Investigate New Anti-inflammatory Drugs
Emilie Branch
Pharma's Almanac
PAO-M01-18-NI-034Jan 19, 2018
Cardiovascular
Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft
Secant Group
PR-M01-18-NI-052-4856Jan 16, 2018